当前位置:首页>产品中心>单抗/多抗>Anti-Human TJP3 Polyclonal Antibody|抗人TJP3多克隆抗体(靶标:人紧密连接蛋白3/ZO-3)

Anti-Human TJP3 Polyclonal Antibody|抗人TJP3多克隆抗体(靶标:人紧密连接蛋白3/ZO-3)

  • 货号:RB9THC970014
  • 价格:面议
  • 点击:550
   一键复制产品信息 复制成功!

产品介绍

产品参数

形态Liquid
宿主种属Rabbit
克隆性Polyclonal
抗体亚型IgG
纯化方式Purified by antigen affinity column.
内毒素水平Please contact with the lab for this information.
应用ELISA, IHC, WB
种属反应性Human
靶标TJP3, Tight junction protein 3, Tight junction protein ZO-3, ZO3, Zona occludens protein 3, Zonula occludens protein 3
免疫原E. coli - derived recombinant Human TJP3 (Ser378-Asp776).
储存缓冲液0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
产品使用说明ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000
登录号O95049
背景信息

Tight junction protein ZO-3 (TJP3) is a ~101 kDa protein. TJP1, TJP2, and TJP3 are closely related scaffolding proteins that link tight junction (TJ) transmembrane proteins such as claudins, junctional adhesion molecules, and occludin to the actin cytoskeleton. The tight junction acts to limit movement of substances through the paracellular space and as a boundary between the compositionally distinct apical and basolateral plasma membrane domains of epithelial and endothelial cells. Binds and recruits PATJ to tight junctions where it connects and stabilizes apical and lateral components of tight junctions. Promotes cell-cycle progression through the sequestration of cyclin D1 (CCND1) at tight junctions during mitosis which prevents CCND1 degradation during M-phase and enables S-phase transition. With TJP1 and TJP2, participates in the junctional retention and stability of the transcription factor DBPA, but is not involved in its shuttling to the nucleus.

1. Michel, D. et al. (2005) Journal of cell science 118, 4049-57. PMID: 16129888
2. Capaldo, CT. et al. (2011) Molecular biology of the cell 22, 1677-85. PMID: 21411630
备注For research use only
【仅供科学研究使用】

相关产品:
产品名称 点击数
Research Grade Lunaxafusp|研究级Lunaxafusp(靶标:Lunaxafusp(研究用)) 538
Anti-Mouse C5 Recombinant Antibody|抗小鼠C5重组抗体(靶标:小鼠补体C5) 422
Anti-Pembrolizumab Neutralizing Recombinant Antibody |抗帕博利珠单抗中和重组抗体(靶标:帕博利珠单抗中和抗体) 323
Anti-Pembrolizumab Neutralizing Recombinant Antibody |抗帕博利珠单抗中和重组抗体(靶标:帕博利珠单抗中和抗体) 227
Anti-Human CD39/ENTPD1 Recombinant Antibody|抗人CD39/ENTPD1重组抗体(靶标:人外核苷酸三磷酸二磷酸水解酶1/CD39) 293
Anti-Glycophorin A (type M) Recombinant Antibody|抗血型糖蛋白A(M型)重组抗体(靶标:人血型糖蛋白A(M型)) 612
Anti-Glycophorin A (type N) Recombinant Antibody|抗血型糖蛋白A(N型)重组抗体(靶标:人血型糖蛋白A(N型)) 268
Anti-Glycophorin A (type N) Recombinant Antibody|抗血型糖蛋白A(N型)重组抗体(靶标:人血型糖蛋白A(N型)) 533
Anti-Glycophorin A (type M) Recombinant Antibody|抗血型糖蛋白A(M型)重组抗体(靶标:人血型糖蛋白A(M型)) 320
Anti-Human α4β7/ITGA4 & ITGB7 Recombinant Antibody |抗人α4β7/ITGA4和ITGB7重组抗体(靶标:人整合素α4β7复合物) 285
Anti-Human CD2BP2 Polyclonal Antibody|抗人CD2BP2多克隆抗体(靶标:人CD2结合蛋白2) 459
InVivoMAb anti-Mouse IL-6R alpha&IL6R Antibody|InVivoMAb抗小鼠IL-6Rα和IL6R抗体(靶标:小鼠白细胞介素6受体) 527
Anti-Human EGFR/ERBB1/HER1 Reference Antibody|抗人EGFR/ERBB1/HER1参照抗体(靶标:人表皮生长因子受体(研究用)) 418
Anti-Human CD279/PD-1 Recombinant Antibody|抗人CD279/PD-1重组抗体(靶标:人程序性细胞死亡蛋白1/PD-1) 514
Anti-Human CD279/PD-1 Recombinant Antibody, FITC|抗人CD279/PD-1重组抗体, FITC标记(靶标:人程序性细胞死亡蛋白1/PD-1(FITC标记)) 527
Anti-Human CD279/PD-1 Recombinant Antibody, PE|抗人CD279/PD-1重组抗体, PE标记(靶标:人程序性细胞死亡蛋白1/PD-1(PE标记)) 416
Anti-Human CD279/PD-1 Recombinant Antibody, APC|抗人CD279/PD-1重组抗体, APC标记(靶标:人程序性细胞死亡蛋白1/PD-1(APC标记)) 645
Anti-Human CD279/PD-1 Recombinant Antibody, PerCP|抗人CD279/PD-1重组抗体, PerCP标记(靶标:人程序性细胞死亡蛋白1/PD-1(PerCP标记)) 511
Anti-Omalizumab Neutralizing Recombinant Antibody |抗奥马珠单抗中和重组抗体(靶标:奥马珠单抗中和抗体) 297
Anti-Omalizumab Neutralizing Recombinant Antibody |抗奥马珠单抗中和重组抗体(靶标:奥马珠单抗中和抗体) 234
总计 33037 个记录,共 1652 页,当前第 1643 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周五每天9:00-17:00